DLX6 and nasopharyngeal carcinoma: Functional assays performed on NPC cell lines (HK-1 and CNE2) with DLX6 shRNA demonstrated that the knockdown of DLX6 effectively reduced its expression, resulting in a marked decrease in the proliferation, migration, and invasion abilities of the cells.